|
|
Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Flecainide#Pharmacology]] |
| {{Flecainide}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Description==
| |
| | |
| Flecainide acetate is an antiarrhythmic drug available in tablets of 50, 100 or 150 mg for oral administration. Flecainide acetate is benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-monoacetate. The structural formula is given below.
| |
| {|
| |
| |[[File:Flecainide03.jpg|thumb|800px]]
| |
| |}
| |
| Flecainide acetate is a white crystalline substance with a pKa of 9.3. It has an aqueous solubility of 48.4 mg/mL at 37°C. | |
| Flecainide acetate tablets also contain: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, methylcellulose and stearic acid.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FLECAINIDE ACETATE TABLET [APOTEX CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72595783-e6a0-6b7a-f428-9ca03d707794#nlm34084-4 | publisher = | date = | accessdate = 11 March 2014 }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| [[Category:Antiarrhythmic agents]]
| |
| [[Category:Piperidines]]
| |
| [[Category:Benzamides]]
| |
| [[Category:Phenol ethers]]
| |
| [[Category:Organofluorides]]
| |
| [[Category:Sodium channel blockers]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |